Back

Resonant acquires Creapharm to expand European biorepository services

Verifying
  • Resonant Clinical Solutions acquired France-based Creapharm Bioservices from Myonex.
  • -196°C to -20°C storage expands Resonant’s European biorepository capabilities.
  • 2025 IQVIA study found non-small-molecule assets comprised 46% of 2024 Phase I–III starts.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.